...
首页> 外文期刊>Molecular Carcinogenesis >c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
【24h】

c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.

机译:c-jun和多阶段癌变:在对肿瘤启动子诱导的转化敏感的小鼠JB6细胞中,引入的c-jun的过度表达与向肿瘤终点的进展有关。

获取原文
获取原文并翻译 | 示例

摘要

Tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and epidermal growth factor (EGF) induce neoplastic transformation, elevated c-jun protein expression, and activator protein-1 (AP-1)-dependent gene expression in JB6 mouse epidermal cells sensitive to tumor promoters (clone 415a P+ cells). In contrast, JB6 cells resistant to tumor promoter-induced transformation (clone 307b P- cells) exhibit a greatly reduced TPA or EGF inducible c-jun expression and AP-1 activity. We have recently shown that induced AP-1 is necessary for tumor promoter-induced transformation of P+ cells because introduction of a dominant negative c-jun mutant into P+ cells inhibits both AP-1 dependent transactivation and the transformation response to tumor promoter. The intent of the investigation presented here was to test the hypothesis that elevation of AP-1 activity is sufficient to cause progression to the P+ phenotype in P- cells or to the transformed phenotype in P+ cells. Clonally derived P+ and P- recipient cells transfected with a human c-jun expression construct and overexpressing c-jun protein were tested for progression by assaying for constitutive or inducible anchorage independent phenotype and nude-mouse tumorigenicity. Overexpression of c-jun did not produce progression in P- cells but did increase the probability of progression in P+ cells (two of five transfectant cell lines progressed to the tumor phenotype). In addition, c-jun overexpression did not increase AP-1 activity in any of the P-/c-jun transfectants or in the two of five P+/c-jun transfectants that acquired the transformed phenotype. The P+/c-jun transfectants that showed elevated AP-1 activity did not progress to the tumor phenotype, demonstrating that an increase in AP-1 activity is insufficient for this progression. Since P(+)-to-tumor phenotype progression occurred in cells overexpressing c-jun but not AP-1, we propose that P(+)-to-transformed phenotype progression is c-jun dependent and AP-1 independent.
机译:肿瘤启动子,例如12-O-十四烷酰phorbol-13-乙酸盐(TPA)和表皮生长因子(EGF)诱导JB6中的肿瘤转化,c-jun蛋白表达升高和激活蛋白1(AP-1)依赖性基因表达。对肿瘤启动子敏感的小鼠表皮细胞(克隆415a P +细胞)。相反,对肿瘤启动子诱导的转化具有抗性的JB6细胞(克隆307b P细胞)显示TPA或EGF诱导的c-jun表达和AP-1活性大大降低。我们最近显示,诱导的AP-1对于肿瘤启动子诱导的P +细胞转化是必需的,因为将显性负性c-jun突变体引入P +细胞会抑制AP-1依赖性反式激活和对肿瘤启动子的转化反应。本文提出的研究目的是检验以下假设:AP-1活性的升高足以引起P-细胞中的P +表型或P +细胞中的转化表型的发展。通过测定组成型或诱导型锚定非依赖性表型和裸鼠致瘤性来测试用人c-jun表达构建体转染并过度表达c-jun蛋白的克隆来源的P +和P-受体细胞的进展。 c-jun的过度表达不会在P细胞中产生进展,但会增加P +细胞中进展的可能性(五种转染细胞系中有两种进展为肿瘤表型)。另外,c-jun过表达在增加转化表型的任何P- / c-jun转染子或五种P + / c-jun转染子中没有增加AP-1活性。显示出升高的AP-1活性的P + / c-jun转染子并未发展为肿瘤表型,这表明AP-1活性的增加不足以促进这种进展。由于P(+)到​​肿瘤表型进展发生在过表达c-jun但不是AP-1的细胞中,我们建议P(+)到​​转化表型进展是c-jun依赖和AP-1独立的。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号